Accelerating pandemic response: The swine flu vaccine

A A A

Accelerating pandemic response: The swine flu vaccine

By Roz Allen @ MaRS

May 4, 2009

Talking Swine Flu at BioFinance

Discussing the recent outbreak of Influenza A Virus H1N1 at last week’s BioFinance, Dr. Gottlieb, former Deputy Commissioner of the FDA, examines the evolution of vaccine manufacturing capacity from the days of Avian flu to the current crisis.

Outbreaks, breakthroughs, and other game-changing events in medical science require the medical industry to respond rapidly, redeploying resources, and altering business strategies to stay relevant in a dynamic market climate. Coming up with ways of hard-coding adaptive agility and market awareness into company operations at an early stage means fewer battles and faster cures down the road.

Accelerating Pandemic Response: The Swine Flu Vaccine from MaRS Discovery District on Vimeo.

Pingback: BioFinance Lunch Keynote: U.S. Health Reform « The Cross-Border Biotech Blog

EnerMotion: Hot Savings for the trucking industry After a recent discussion with friends regarding greenhouse gas emissions in the transportation industry, I walked away realizing

The lean rock band They don’t tell you this at your first guitar lesson, but to succeed as a musician you need more than just killer chops and a re

What is a culture of innovation? Note: Through the research she conducted for her PhD dissertation, Nicola Hepburn made some key discoveries about innovation i

School for Social Entrepreneurs Ontario gets ready to graduate its first cohort Early in 2008, just as MaRS launched its programming to support social entrepreneurs, Sarah Evans, daughter-in-law of one of MaRS�